MDS Sciex Reports 4-Percent Rise in Organic Q4 Revenue | GenomeWeb
NEW YORK (GenomeWeb News) — MDS today reported that first-quarter revenue for its Sciex division increased 1.5 percent, though organic receipts increased 4 percent.
 
Total revenue for the three months ended Dec. 31, 2006, increased to $62 million from $61 million.
 
Driving revenue were the small molecule and applied markets and in Europe, MDS said.
 
MDS also said end-user revenue in the company’s joint ventures increased 10 percent.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.